Understanding how Chlamydia bacteria divide and grow
Regulation of Chlamydial Divisome Assembly
This study is looking at how the Chlamydia bacteria grow and divide in a different way than most germs, which could help us find new ways to treat infections caused by it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Health Sci Ctr NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project ID | NIH-11224656 on NIH RePORTER |
What this research studies
This research investigates the unique way that Chlamydia trachomatis, a common cause of sexually transmitted infections, divides and grows. Unlike most bacteria, Chlamydia does not use the typical binary fission process, and instead, it employs a specialized budding mechanism. The study aims to uncover the molecular machinery and regulatory processes involved in this unusual division, which could lead to new insights into bacterial growth and potential treatment strategies. By examining the roles of specific proteins and DNA interactions, researchers hope to better understand how this pathogen operates at a cellular level.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Chlamydia trachomatis infections or those at high risk for such infections.
Not a fit: Patients with infections caused by other bacteria or those who do not have Chlamydia trachomatis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches for treating Chlamydia infections and improving patient outcomes.
How similar studies have performed: While the specific approach of studying Chlamydia's unique division mechanism is novel, similar research on bacterial division processes has shown promising results in understanding other pathogens.
Where this research is happening
Memphis, United States
- University of Tennessee Health Sci Ctr — Memphis, United States (Active)
Researchers
- Principal investigator: Cox, John Vincent — University of Tennessee Health Sci Ctr
- Study coordinator: Cox, John Vincent
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.